Your browser doesn't support javascript.
loading
MicroRNA-16 Restores Sensitivity to Tyrosine Kinase Inhibitors and Outperforms MEK Inhibitors in KRAS-Mutated Non-Small Cell Lung Cancer.
Fanini, Francesca; Bandini, Erika; Plousiou, Meropi; Carloni, Silvia; Wise, Petra; Neviani, Paolo; Murtadha, Mariam; Foca, Flavia; Fabbri, Francesco; Vannini, Ivan; Fabbri, Muller.
Afiliación
  • Fanini F; Immuno-Gene Therapy Factory, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", 47014 Meldola, Italy.
  • Bandini E; Biosciences Laboratory, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", 47014 Meldola, Italy.
  • Plousiou M; Biosciences Laboratory, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", 47014 Meldola, Italy.
  • Carloni S; Immuno-Gene Therapy Factory, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", 47014 Meldola, Italy.
  • Wise P; Department of Microgravity and Translational Regenerative Medicine, Clinic for Plastic, Aesthetic and Hand Surgery, Otto von Guericke University, 39106 Magdeburg, Germany.
  • Neviani P; Extracellular Vesicle Core, The Saban Research Institute, Children's Hospital Los Angeles, Los Angeles, CA 90027, USA.
  • Murtadha M; Judy and Bernard Briskin Center for Multiple Myeloma Research, Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Monrovia, CA 91016, USA.
  • Foca F; Unit of Biostatistics and Clinical Trials, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", 47014 Meldola, Italy.
  • Fabbri F; Biosciences Laboratory, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", 47014 Meldola, Italy.
  • Vannini I; Biosciences Laboratory, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", 47014 Meldola, Italy.
  • Fabbri M; Center for Cancer and Immunology Research, Children's National Hospital, Washington, DC 20010, USA.
Int J Mol Sci ; 22(24)2021 Dec 12.
Article en En | MEDLINE | ID: mdl-34948154

Texto completo: 1 Base de datos: MEDLINE Asunto principal: ARN Neoplásico / Proteínas Proto-Oncogénicas p21(ras) / Carcinoma de Pulmón de Células no Pequeñas / Resistencia a Antineoplásicos / Quinasas Quinasa Quinasa PAM / MicroARNs / Inhibidores de Proteínas Quinasas / Neoplasias Pulmonares / Mutación Tipo de estudio: Diagnostic_studies / Prognostic_studies Idioma: En Revista: Int J Mol Sci Año: 2021 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: ARN Neoplásico / Proteínas Proto-Oncogénicas p21(ras) / Carcinoma de Pulmón de Células no Pequeñas / Resistencia a Antineoplásicos / Quinasas Quinasa Quinasa PAM / MicroARNs / Inhibidores de Proteínas Quinasas / Neoplasias Pulmonares / Mutación Tipo de estudio: Diagnostic_studies / Prognostic_studies Idioma: En Revista: Int J Mol Sci Año: 2021 Tipo del documento: Article